Clinivation builds its process solutions practice with expertise and organizational knowledge.
Framingham, MA, July 31, 2001 – clinivation, Inc. announced today that it has acquired the clinical development and regulatory services business units of PROFORMANT, Inc.
“Our acquisition of PROFORMANT’s highly-successful clinical development and regulatory services business units by clinivation enables us to extend our infrastructure and process solutions with expertise and organizational knowledge,” said Joseph Kozikowski, M.D., Chairman and Chief Technology Officer of clinivation. “The transaction also increases clinivation’s top-line growth,” he said.
PROFORMANT’s clinical development and regulatory services business units have enabled clients to rapidly achieve the major milestones of pre-production GMP quality operations, product clinical feasibility, product clinical validation, and FDA approvals. The teams specialized in turnkey, integrated execution of the entire set of external preclinical, clinical, regulatory, and approval activities for medical device and diagnostic companies. As a complete-mission-capable CRO, the teams expedited numerous multi-center clinical development programs and FDA product approvals on timelines far shorter than industry averages.
“The clinical development and regulatory knowledge generated by these activities are of tremendous value to our infrastructure and process solutions mission,” said Dr. Kozikowski.
Under the terms of a subsequent alliance, PROFORMANT and clinivation will share knowledge, training, staff, and other resources in a way that extends and enriches each company’s service products.
About PROFORMANT, Inc.
PROFORMANT delivers expertise and strategic consulting that enables pharmaceutical, biotechnology, medical device, and diagnostics companies to achieve new milestones of growth, competitive advantage, and value.
Visit PROFORMANT online at www.proformant.com